Comparison of three group of Hyperbaric spinal drugs in Lower abdominal surgeries done in spinal anaesthesia

Comparision of 0.75% intrathecal hyperbaric ropivacaine, 0.5% hyperbaric levo-bupivacaine, and 0.5% hyperbaric bupivacaine with fentanyl 25mcg as common adjuvant to all three groups in lower abdominal surgeries - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056895

Enrollment

Registered

2023-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Comparison of hyperbaric local anaesthetic drugs: Comparision of 0.75% intrathecal hyperbaric ropivacaine, 0.5% hyperbaric bupivacaine, 0.5% hyperbaric levobupivacaine with fentanyl 25m

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 18years and less than 60 years 2.ASA Grade I and II patietns 3.Patient giving valid informed consent. 4.Lower Abdominal surgeries taken under only spinal anaesthesia 5. Both male and female patients

Exclusion criteria

Exclusion criteria: 1.age more than 60 years and less than 18 years 2.ASA grade 3 & 4. 3.Patient refusal. 4.Patients with local infection at puncturing site. 5.Patients with Ischemic and Rheumatic heart diseases. 6.Patients with coagulation defects and patients on anticoagulants. 7.Patients allergic to local anesthetic drugs. 8. Surgeries converted to general anaesthesia.

Design outcomes

Primary

Measure	Time frame
Determine the onset of sensory & motor blockadeTimepoint: At Baseline	—

Secondary

Measure	Time frame
Duration of motor blockade & oveall hemodynamic changesTimepoint: After 3 hours	—

Countries

India

Contacts

Public ContactDr Dinesh Kumar P

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals

cruise2010.mmc@gmail.com09489221297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026